» Articles » PMID: 37969243

Sudden Cardiac Arrest in the Paediatric Population

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Sudden cardiac arrest in the young is a rare event with a range of potential causes including cardiomyopathies, ion channelopathies, and autonomic nervous system dysfunction. Investigations into the cause involve a multidisciplinary team, including cardiologists, geneticists, and psychologists. In addition to a detailed medical history, family history and circumstances surrounding the event are important in determining the cause. Clinical investigations including an electrocardiogram are fundamental in diagnosis and should be interpreted cautiously because some children may have atypical presentations and an evolving phenotype. The potential for misdiagnosis exists that could lead to incorrect long-term management strategies. If an inherited condition is suspected, genetic testing of the patient and cascade screening of family members is recommended with genetic counselling and psychological support. Medical management is left to the treating physician acknowledging that a clear diagnosis cannot be made in approximately half of cases. Secondary prevention implantable defibrillators are widely deployed but can be associated with complications in young patients. A plan for safe return to activity is recommended along with a proper transition of care into adulthood. Broad screening of the general population for arrhythmia syndromes is not recommended; preventative measures include screening paediatric patients for risk factors by their primary care physician. Several milestone events or activities that take place in youth could be used as opportunities to promote safety. Further work into risk stratification of this paediatric population through patient registries and greater awareness of cardiopulmonary resuscitation and automated external defibrillator use in saving lives is warranted.

Citing Articles

Incidence and trend of cardiac events among children and young adults exposed to psychopharmacological treatment (2006-2018): A nationwide register-based study.

Elmowafi H, Kindblom J, Halldner L, Gyllenberg D, Naumburg E Br J Clin Pharmacol. 2024; 91(3):817-828.

PMID: 39448545 PMC: 11862795. DOI: 10.1111/bcp.16321.

References
1.
Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc J, Thomsen P . Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J. 2004; 25(22):2054-72. DOI: 10.1016/j.ehj.2004.09.004. View

2.
Sheppard M . Sudden Death in Congenital Heart Disease: The Role of the Autopsy in Determining the Actual Cause. J Cardiovasc Dev Dis. 2020; 7(4). PMC: 7766481. DOI: 10.3390/jcdd7040058. View

3.
Arnestad M, Crotti L, Rognum T, Insolia R, Pedrazzini M, Ferrandi C . Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007; 115(3):361-7. DOI: 10.1161/CIRCULATIONAHA.106.658021. View

4.
Etheridge S, Escudero C, Blaufox A, Law I, Dechert-Crooks B, Stephenson E . Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study. JACC Clin Electrophysiol. 2018; 4(4):433-444. DOI: 10.1016/j.jacep.2017.10.009. View

5.
Visser M, van der Heijden J, Doevendans P, Loh P, Wilde A, Hassink R . Idiopathic Ventricular Fibrillation: The Struggle for Definition, Diagnosis, and Follow-Up. Circ Arrhythm Electrophysiol. 2016; 9(5). DOI: 10.1161/CIRCEP.115.003817. View